We suggest that the EMF exposure represents a second hit, affecting SC development in predisposed and susceptible human subjects (specifically, those bearing NF2 mutations or changes in merlin expression) prone to developing VS and subsequent HL. This evidence concerns the gene NF2 and Hodgkins lymphoma.